Paul Tudor Jones Tudor Investment Corp
Paul Tudor Jones is the founder of Tudor Investment Corporation and a pioneering macro trader. He rose to prominence after navigating the 1987 market crash successfully and has since built a multi-strategy firm spanning global markets. Jones is widely associated with discretionary macro trading, risk management discipline, and high-profile philanthropic efforts in education and the environment.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$662M |
| 2 |
Invesco QQQ Trust
QQQ
|
+$116M |
| 3 |
Broadcom
AVGO
|
+$96.2M |
| 4 |
Walmart Inc
WMT
|
+$91.2M |
| 5 |
ITCI
Intra-Cellular Therapies Inc.
ITCI
|
+$77.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Bitcoin Trust
IBIT
|
+$175M |
| 2 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$152M |
| 3 |
iShares Core S&P 500 ETF
IVV
|
+$149M |
| 4 |
INFN
Infinera Corporation Common Stock
INFN
|
+$108M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$70.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 5.92% |
| 2 | Financials | 4.33% |
| 3 | Healthcare | 3.85% |
| 4 | Consumer Discretionary | 3.59% |
| 5 | Industrials | 3.49% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Reinsurance Group of America
RGA
$15.9B
| $22.8M | 0.08% |
115,820
+9,378
| +9% | +$1.94M |
|
177
PUT
IBM
IBM
$222B
| $22.8M | 0.08% |
91,700
-79,700
| -46% | -$19.5M |
|
178
CALL
Berkshire Hathaway Class B
BRK.B
$1.06T
| $22.7M | 0.08% |
42,600
+19,000
| +81% | +$9.24M |
|
179
Royalty Pharma
RPRX
$27.3B
| $22.7M | 0.08% |
727,736
-7,291
| -1% | -$231K |
|
180
Choice Hotels
CHH
$4.93B
| $22.6M | 0.08% |
+170,348
| New | +$24.3M |
|
181
CALL
Apple
AAPL
$4.51T
| $22.6M | 0.08% |
101,700
-183,200
| -64% | -$42.4M |
|
182
iShares MSCI Canada ETF
EWC
$6.6B
| $22.5M | 0.07% |
+551,909
| New | +$22.6M |
|
183
State Street Financial Select Sector SPDR ETF
XLF
$57.8B
| $22.4M | 0.07% |
450,135
-549,865
| -55% | -$27.6M |
|
|
ML
184
DELISTED
MoneyLion Inc.
ML
| $22.4M | 0.07% |
258,934
+113,931
| +79% | +$9.89M |
|
185
PUT
Netflix
NFLX
$331B
| $22.4M | 0.07% |
240,000
+44,000
| +22% | +$4.18M |
|
186
PUT
Constellation Energy
CEG
$96.7B
| $22.4M | 0.07% |
110,900
+37,800
| +52% | +$10.1M |
|
187
CALL
JPMorgan Chase
JPM
$935B
| $22.2M | 0.07% |
90,500
-11,100
| -11% | -$2.83M |
|
188
Chewy
CHWY
$9.83B
| $22.2M | 0.07% |
682,423
+527,008
| +339% | +$18.9M |
|
189
Lam Research
LRCX
$393B
| $22.1M | 0.07% |
304,505
+106,040
| +53% | +$8.35M |
|
190
Toll Brothers
TOL
$13.7B
| $22M | 0.07% |
208,322
+192,015
| +1,178% | +$23.1M |
|
191
HP
HPQ
$27.2B
| $21.9M | 0.07% |
790,096
+574,910
| +267% | +$18.2M |
|
192
Synaptics
SYNA
$3.82B
| $21.8M | 0.07% |
342,263
+240,677
| +237% | +$17.4M |
|
193
CALL
Celsius Holdings
CELH
$8.44B
| $21.8M | 0.07% |
610,900
+191,300
| +46% | +$5.21M |
|
194
PG&E
PCG
$38.8B
| $21.6M | 0.07% |
500,000
+100,000
| +25% | +$1.66M |
|
|
XYZ
195
PUT
Block Inc
XYZ
$49.4B
| $21.6M | 0.07% |
397,900
+393,300
| +8,550% | +$29.4M |
|
196
TechnipFMC
FTI
$30.4B
| $21.5M | 0.07% |
677,441
+387,189
| +133% | +$11.6M |
|
197
PUT
Costco
COST
$420B
| $21.4M | 0.07% |
22,600
+21,500
| +1,955% | +$21M |
|
198
Vistra
VST
$45.7B
| $21.3M | 0.07% |
181,354
+89,427
| +97% | +$13.4M |
|
199
PUT
United Airlines
UAL
$36.7B
| $21.1M | 0.07% |
306,100
+149,700
| +96% | +$14.1M |
|
200
Curtiss-Wright
CW
$23.5B
| $21.1M | 0.07% |
+66,565
| New | +$22.5M |
|
Similar funds
Paul Tudor Jones's Q1 2025 Portfolio in Review
As of Q1 2025, Paul Tudor Jones held 3,818 positions worth $30.1B, up 15% from $26.3B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
Paul Tudor Jones deployed $6.13B of net new capital in Q1 2025, opening 874 new positions and adding to 1,161 existing holdings. Its largest new stake was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
By sector, the portfolio is most concentrated in Technology at 5.9% of assets, down from 6.4% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was iShares Bitcoin Trust, an estimated $175M trimmed.
- Paul Tudor Jones's largest Q1 2025 buy was Intra-Cellular Therapies Inc.: 621,815 shares worth $82M.
- Paul Tudor Jones added most to iShares Russell 2000 ETF in Q1 2025, an estimated $662M increase.
- Paul Tudor Jones's biggest Q1 2025 reduction was iShares Bitcoin Trust, cutting an estimated $175M.
- Paul Tudor Jones fully exited Infinera Corporation Common Stock in Q1 2025, selling an estimated $108M.
- Paul Tudor Jones's ten largest holdings make up 40% of its $30.1B portfolio in Q1 2025.
- Paul Tudor Jones opened 874 new positions and closed 844 in Q1 2025.
- Paul Tudor Jones's portfolio value rose 15% quarter-over-quarter to $30.1B.
Based on Tudor Investment Corp's 13F filing for Q1 2025, filed 15 May 2025.